Stock 300871 HVSEN BIOTECHNOLOGY CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

All News Hvsen Biotechnology Co., Ltd.

Equities

300871

CNE1000047H6

End-of-day quote Shenzhen S.E.
Other stock markets
 03:30:00 06/06/2024 am IST 		5-day change 1st Jan Change
10.21 CNY -5.99% Intraday chart for Hvsen Biotechnology Co., Ltd. -17.06% -29.39%
24/04 Hvsen Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
03/04 Hvsen Biotechnology Co., Ltd. announced a financing transaction CI

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Hvsen Biotechnology Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2023, Payable on 29 May 2024
CI
Hvsen Biotechnology Co., Ltd. Proposes Final Cash Dividend for 2023
CI
Hvsen Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Hvsen Biotechnology Co., Ltd. announced a financing transaction
CI
Tech-Bank Food Co., Ltd. announced that it has received CNY 1.197979975 billion in funding from a group of investors
CI
Hvsen Biotechnology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
Hvsen Biotechnology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Certain A Shares of Hvsen Biotechnology Co., Ltd. are subject to a Lock-Up Agreement Ending on 24-AUG-2023.
CI
Hvsen Biotechnology Co., Ltd. Implements Cash Dividend of A Shares for 2022, Payable on 21 June 2023
CI
Hvsen Biotechnology Co., Ltd. Approves Cash Dividend for the Year 2022
CI
Hvsen Biotechnology Co., Ltd. Proposes Final Cash Dividend for the Year 2022
CI
Hvsen Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Hvsen Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Tranche Update on Hvsen Biotechnology Co., Ltd.'s Equity Buyback Plan announced on April 22, 2022.
CI
Hvsen Biotechnology Co., Ltd.'s Equity Buyback announced on April 22, 2022, has expired with 2,389,050 shares, representing 1.44% for CNY 50.02 million.
CI
Tranche Update on Hvsen Biotechnology Co., Ltd.'s Equity Buyback Plan announced on April 22, 2022.
CI
Tranche Update on Hvsen Biotechnology Co., Ltd.'s Equity Buyback Plan announced on April 22, 2022.
CI
Hvsen Biotechnology Co., Ltd. Approves Board Appointments
CI
Hvsen Biotechnology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
CI
Hubei Huisheng Biotechnology Co., Ltd. announced that it expects to receive CNY 700 million in funding from Hvsen Biotechnology Co., Ltd.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 300871 Stock
  4. News Hvsen Biotechnology Co., Ltd.